Lifeway Foods Faces Potential Sale to Danone Amidst Board Overhaul and Family Feud Resolution by June 2025
Danone offered to buy Lifeway at $25/share in September 2024, raised to $27/share in November 2024.
388 Views
Ping An's Strategic Buyout of OneConnect: Navigating Shareholder Approval and Financial Implications Amidst Declining Performance
OneConnect received a non-binding acquisition proposal from Ping An Group at $7.98/ADS, requiring 75% shareholder approval.
1.1k Views
Sun Pharma's Acquisition of Checkpoint Therapeutics: Analyzing the CVR Payout Potential and Strategic Implications
Checkpoint Therapeutics is being acquired by Sun Pharma for $4.1/share plus a non-transferable CVR worth up to $0.70/share.
472 Views
SSI Weekly: WEX Tender Offer, SGRP Gains, OCI Asset Sale, CURN Strategy, and Quick Pitch Updates
WEX Inc. launched a $750m tender offer with an odd-lot provision, targeting to repurchase ~12% of shares. OCI N.V.'s Natgasoline JV dispute...
396 Views
WEX Launches $750M Tender Offer with Odd-Lot Provision Amidst Share Price Decline and Strategic Stake Increase
WEX launched a $750m tender offer to repurchase ~12% of shares at $148-$170/share, prioritizing odd lots.
860 Views